CapRI: Final results of the open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon-alpha 2b (CRI) versus 5-FU alone for patients with resected pancreatic adenocarcinoma (PAC)

Marten, A. and Schmidt, J. and Debus, J. and Harig, S. and Lindel, K. and Klein, J. and Bartsch, D. K. and Capussotti, L. and Zuelke, C. and Buchler, M. (2010) CapRI: Final results of the open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon-alpha 2b (CRI) versus 5-FU alone for patients with resected pancreatic adenocarcinoma (PAC). JOURNAL OF CLINICAL ONCOLOGY, 28 (18supp): LBA4012. ISSN 0732-183X, 1527-7755

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Chirurgie
Depositing User: Petra Gürster
Date Deposited: 16 Apr 2020 08:28
Last Modified: 16 Apr 2020 08:28
URI: https://pred.uni-regensburg.de/id/eprint/24553

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.